Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Catabasis Pharma (CATB)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Catabasis Pharma One Kendall Square Bldg. 1400E Suite B14202 Cambridge MA 02139 USA

P: 617-349-1971 F: 617-273-2637

Description:

Catabasis Pharmaceuticals, Inc. is a biopharmaceutical company. The Company focuses on the discovery, development and commercialization of therapeutics for treatment of inflammatory, immunological and metabolic diseases. Its product development pipeline includes CAT-1004, CAT-2000 series including CAT-2054 and CAT-2003, CAT-4001 as well as various programs which are in different clinical-stage. Catabasis Pharmaceuticals, Inc. is based in Cambridge, Massachusetts.

Key Statistics

Overview:

Market Capitalization, $K 83,913
Shares Outstanding, K 11,495
Annual Sales, $ 500 K
Annual Net Income, $ -25,870 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -6,060 K
60-Month Beta 1.64
% of Insider Shareholders 8.60%
% of Institutional Shareholders 33.59%
Float, K 10,506
% Float 91.40%

Growth:

1-Year Return -62.24%
3-Year Return -85.96%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Next Earnings Date 05/09/19
Earnings Per Share ttm -6.55
EPS Growth vs. Prev Qtr -6.25%
EPS Growth vs. Prev Year 64.58%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00
Most Recent Split 1-10 on 12/31/18

CATB Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward -1.05
Price/Earnings to Growth N/A
Return-on-Equity (After Tax) -77.11
Return-on-Assets (Before Tax) -67.64
Net Margin % N/A
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 1.52
Book Value/Share 4.92
Interest Coverage -257.70
Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar